Trevi Therapeutics, Inc.
USD18.85
+0.22 (+1.18%)
CEO
Jennifer L. Good
IPO Date
2019-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.49
Prev. Close
$18.63
Day Low
$18.46
Day High
$19.01
52W Low
$5.47
52W High
$19.00
Market Cap
$2.68B
Volume
0.08M
| -8.7 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -35.2% | -32.5% | 0.02 | 15.03 | -4.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -27.1% | -23.7% | 0.09 | 9.15 | -4.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -198.8% | -88.2% | 0.86 | 2.98 | -0.5 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -120.1% | -69.5% | 0.52 | 8.33 | -1.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -47.8% | -43.4% | 0.01 | 11.45 | -2.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -118.7% | -100.3% | 0.06 | 7.02 | -3.4 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -87.0% | -57.9% | 0.36 | 3.11 | -5.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 63.7% | -131.8% | -1.27 | 0.41 | -11.5 |
| -54.8 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -6.2% | -5.9% | 0.00 | 21.93 | -28.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -6.2% | -5.9% | 0.00 | 22.42 | -14.5 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -10.4% | -9.7% | 0.01 | 15.38 | -17.9 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -11.5% | -10.3% | 0.01 | 10.41 | -9.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -22.5% | -19.2% | 0.02 | 7.38 | -6.4 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -18.7% | -16.7% | 0.02 | 10.68 | -5.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -15.1% | -13.9% | 0.02 | 14.55 | -7.7 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -9.5% | -8.7% | 0.02 | 15.03 | -4.3 |